Health Tonix Pharmaceuticals Presents Development Update on Potential Smallpox and Monkeypox Vaccine TNX-801 in an Oral Presentation at the World Vaccine and Immunotherapy Congress December 1, 2022
Health ELEVEN EXPERTS FROM LEADING MEDICAL INSTITUTIONS AND EIGHT EXPERTS FROM EISAI* PUBLISH FULL RESULTS OF LECANEMAB PHASE 3 CONFIRMATORY CLARITY AD STUDY FOR EARLY ALZHEIMER’S DISEASE IN THE NEW ENGLAND JOURNAL OF MEDICINE November 30, 2022
Health Eisai Presents Full Results of Lecanemab Phase 3 Confirmatory Clarity Ad Study for Early Alzheimer’s Disease at Clinical Trials on Alzheimer’s Disease (CTAD) Conference November 30, 2022
Health Biora Therapeutics Licenses Preeclampsia Rule-Out Test for Commercial Development November 30, 2022
Health Cosmos Health Enters the Development Phase for CCX0722, an Innovative Product for Obesity and Weight Management November 30, 2022
Health Guardion Health Sciences Announces Pricing of Aggregate $4.75 Million Institutional Private Placement of Series C and Series D Redeemable Preferred Stock November 30, 2022
Health Tonix Pharmaceuticals Announced Data from its Fully Human anti-SARS-CoV-2 Monoclonal Antibody Platform in an Oral Presentation at the World Antiviral Congress November 30, 2022
Health WuXi AppTec Receives 2022 Global Contract Research, Development and Manufacturing Organization Company of the Year Award from Frost & Sullivan November 30, 2022
Health Eleven Experts from Leading Medical Institutions and Eight Experts from Eisai Publish Full Results of Lecanemab Phase 3 Confirmatory Clarity Ad Study for Early Alzheimer’s Disease in the New England Journal of Medicine November 30, 2022
Search
Health
December 1, 2022
November 30, 2022
November 30, 2022
November 30, 2022
November 30, 2022
November 30, 2022
November 30, 2022
November 30, 2022
November 30, 2022
November 30, 2022
